vials

Promising New Candidate to Treat Influenza Infections

A Better Drug Candidate to Treat Influenza Infections Influenza viruses are responsible for over 600,000 deaths globally and have a huge impact on human health and productivity. However, the moderate efficacy of influenza vaccines means that many individuals, particularly the elderly, still develop influenza infections even with vaccination. Current drug treatments for influenza infections include…
VascuLife Basal Medium LM-0002

VascuLife® Basal Medium

VascuLife® Basal Medium is a low serum medium specifically balanced and supplemented for the culture of Primary Human Endothelial Cells and Primary Human Smooth Muscle Cells. VascuLife Endothelial Medium is optimized to maximize Primary Cell life expectancy. VascuLife endothelial basal medium contains no antimicrobials and no phenol red, since these components can cause cell stress…